SCHEMBL4825305

SCHEMBL4825305

NC(=O)S(=O)(=O)CCNc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.54
ALDH1A1 P00352 8/20 0.52
GLA P06280 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
HPGD P15428 2/20 0.50
ALOX12 P18054 1/20 0.50
KDM4E B2RXH2 2/20 0.49
RAB9A P51151 1/20 0.49
GAA P10253 2/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6255056 0.81 MAPT (0.59) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL4820005 0.81 MAPT (0.59) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL4825540 0.81 MAPT (0.49) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL4819578 0.80 MAPT (0.57) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL10341645 0.80 MAPT (0.60) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL4824657 0.80 RAB9A (0.41) MAPTMEN1KMT2ARAB9AGAA
SCHEMBL4824452 0.78 MAPT (0.63) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL4819570 0.78 MAPT (0.59) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL4816136 0.78 MAPT (0.59) MAPTALDH1A1GLASMN1; SMN2MEN1
SCHEMBL24648 0.77 MAPT (0.62) MAPTALDH1A1GLASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7347879-B2 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'Oreál, S.A. (FR) 2008-03-25 US disclosed
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'OREAL S.A. (FR) 2006-01-12 US disclosed
EP-1568687-A1 Sulphur-containing secondary para-Phenylenediamines, dying composition containing such para-phenylenediamines and methods using this composition and use L'OREAL (FR) 2005-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof KRT18, CDC73, DSG1 MAPT 2238/4885ALDH1A1 1148/4885GLA 2018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.